Cancer Immunotherapy: where will the future opportunities be?

Description: Cell therapies are an important treatment approach in immuno-oncology. They have tremendous potential in treating disease but face their own unique challenges in development and production. In this webinar, five speakers in the research and development space discuss key development points for the field and hurdles that are being addressed to develop better tools for production and qualification of these therapies. They also discuss potential next phases of cancer immunotherapy, the long-term opportunities, and the challenges that lie ahead. Featured is our very own, Veronique Baron, Scientific Applications Manager, who presents on the tools that BPS Bioscience provides to enable cell therapy research.
BPS Bioscience Immunotherapy Products: bpsbioscience....
LinkedIn: / bps-bioscience-inc
Company Website: bpsbioscience....
Twitter: / bpsbioscience
Facebook: / bpsbioscience

[@josealvarez9237]

The cell therapies will be essential in immuno-oncology, but the principal protagonists are not going to be CAR-T therapies, the protagonists are going to be CAR-NK therapies, with clever receptors.

[@abc10927]

volume is too low.

[@walterlippmann9496]

I think you have hearing issues